Bio-Rad Labs Inc. A buy Royal Bank of Canada
Start price
16.02.24
/
50%
€316.20
Target price
16.02.25
€445.58
Performance (%)
-21.06%
Price
08.05.24
€249.60
Summary
This prediction is currently active. The prediction for Bio-Rad Labs Inc. A disappoints with a performance of -21.06%. This prediction currently runs until 16.02.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Bio-Rad Labs Inc. A | -1.227% | -1.227% |
iShares Core DAX® | 3.178% | 0.980% |
iShares Nasdaq 100 | 2.972% | 0.925% |
iShares Nikkei 225® | 0.545% | -4.556% |
iShares S&P 500 | 2.367% | 0.833% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Bio-Rad Labs Inc. A diskutieren
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target lowered by analysts at Royal Bank of Canada from $484.00 to $480.00. They now have an "outperform" rating on the stock.
Ratings data for BIO provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€363.40
04.08.23
04.08.23
€474.64
04.08.24
04.08.24
-31.32%
08.05.24
08.05.24